805 participants
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2020-01-30
- Completion:
- 2026-07-20
Conditions
- Prostate Cancer
Interventions
- DRUG
No Results Yet